SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-20-000040
Filing Date
2020-11-02
Accepted
2020-11-02 07:07:16
Documents
16
Period of Report
2020-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K isee-20201102.htm   iXBRL 8-K 35842
2 EX-99 isee3qearningspressrel.htm EX-99 66037
8 image_01a.jpg GRAPHIC 50717
  Complete submission text file 0001410939-20-000040.txt   327709

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20201102.xsd EX-101.SCH 2442
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isee-20201102_cal.xml EX-101.CAL 727
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isee-20201102_def.xml EX-101.DEF 1665
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20201102_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20201102_pre.xml EX-101.PRE 13207
9 EXTRACTED XBRL INSTANCE DOCUMENT isee-20201102_htm.xml XML 10962
Mailing Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119
Business Address ONE PENN PLAZA 35TH FLOOR NEW YORK NY 10119 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 201278955
SIC: 2834 Pharmaceutical Preparations